Pharmacogenomics: the genetics of variable drug responses. - Wikidata - wikimedia - TriplyDB

Pharmacogenomics: the genetics of variable drug responses.

Pharmacogenomics: the genetics of variable drug responses.

http://www.wikidata.org/entity/Q34976915

about

Role of genomics in eliminating health disparities Cardiovascular pharmacogenomics: current status and future directions Pharmacogenetics, pharmacogenomics and ayurgenomics for personalized medicine: a paradigm shift An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care Genetics and cardiovascular disease: a policy statement from the American Heart Association.Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network Mapping genes that predict treatment outcome in admixed populations Personalizing health care: feasibility and future implications.Pharmacogenomics: will the promise be fulfilled?A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes Genes and Cardiovascular Disease: Where do we go from here?Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval.Clinical considerations of heritable factors in common heart failure The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy.Strategies for personalized medicine-based research and implementation in the clinical workflow.Role of genotype-based personalized antiplatelet therapy in the era of potent P2Y₁₂ receptor inhibitors.To replicate or not to replicate: the case of pharmacogenetic studies: Establishing validity of pharmacogenomic findings: from replication to triangulation.Single nucleotide polymorphism and its dynamics for pharmacogenomics.Clinical association between pharmacogenomics and adverse drug reactions.Through a glass darkly: economics and personalised medicine.Genotyping NUDT15 can predict the dose reduction of 6-MP for children with acute lymphoblastic leukemia especially at a preschool age.Pharmacogenomic variants have larger effect sizes than genetic variants associated with other dichotomous complex traits.Perspective on the Genetic Response to Antiparasitics: A Review Article.Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis.Genome-wide and Phenome-wide Approaches to Understand Variable Drug Actions in Electronic Health Records.Big data from electronic health records for early and late translational cardiovascular research: challenges and potential.Network, Transcriptomic and Genomic Features Differentiate Genes Relevant for Drug Response Frequencies of poor metabolizer alleles of 12 pharmacogenomic actionable genes in Punjabi Sikhs of Indian Origin

P2860

Q26782236-5E41CFDF-7C6A-4577-B8BC-91395AB09527 Q26801183-80906891-37F5-43F6-B90A-E00B2B0152FC Q28088445-12C613FE-8D38-4F1A-B21B-DBEAE21298D6 Q28538389-2C5251E6-599C-426F-973E-4C0DA1910E12 Q30418104-CF608299-002D-4AD9-8D59-96BE08372E2E Q31043647-6832F150-DDF8-467F-8129-B1BD5E0BAE62 Q34348337-F12D39BD-1241-4517-9BD0-FA17BC13A6C0 Q34938911-2B85507D-690C-42B8-868D-F0EFCF77071C Q34994860-D102D1E2-A527-4F4F-8E65-4EEDA7A8D538 Q35783016-1AF3C391-11A3-43A9-9C2F-DD61F3D5C930 Q36331319-1A08D65B-C4F5-483A-A584-EC66D8331807 Q37154348-A896B915-937C-4C9D-917B-F2E4CA31FB59 Q37970334-88B637A0-BA0E-413C-9A02-F78C20EF3A1C Q38003702-898726FF-7E20-4BA1-9E2D-3FE047763564 Q38036525-9D0AD41C-D883-4949-B217-B31D5D4B6640 Q38048837-D83CF9E5-467A-44A2-8C79-FFBCB965268C Q38130427-1F2DD532-98D1-4A1F-B086-793A469F15C7 Q38244756-2E5DA174-BA1E-4A35-98EB-F79930C2B6A7 Q38431150-83B88A94-5584-44F8-80CC-98648680A5EC Q39145520-252A9157-6ED0-4872-85BD-3739F6EBE417 Q39756044-2BEF5C35-6ADB-46AC-9EB6-7F141B8BA895 Q41945248-5518F347-CAF4-4140-84B0-0AE6C366D58E Q47308561-995E8B2B-D39A-4591-972F-036889BC13F6 Q47786696-90CB43B7-3927-4C78-94AF-A4C8EC9A88C1 Q49931634-6E9E41D0-5671-4BAB-81AF-77A06C698D3C Q52705350-DF199EEB-EFD7-4A4E-8A34-431FF0D15D56 Q57491987-FB12995A-1AE9-469F-A112-2BAAA7D25FDE Q57794673-78335F99-B8D1-4FFC-8B95-0FAF800CB80C

P2860

Pharmacogenomics: the genetics of variable drug responses.

http://www.wikidata.org/entity/Q34976915

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pharmacogenomics: the genetics of variable drug responses.

@ast

Pharmacogenomics: the genetics of variable drug responses.

@en

Pharmacogenomics: the genetics of variable drug responses.

@nl

type

label

Pharmacogenomics: the genetics of variable drug responses.

@ast

Pharmacogenomics: the genetics of variable drug responses.

@en

Pharmacogenomics: the genetics of variable drug responses.

@nl

prefLabel

Pharmacogenomics: the genetics of variable drug responses.

@ast

Pharmacogenomics: the genetics of variable drug responses.

@en

Pharmacogenomics: the genetics of variable drug responses.

@nl

P1433

Q34976915-AD2A21A8-3806-4E1A-8EC8-C3C71588037A

P1476

Q34976915-75E740B3-64C9-429F-B502-378DB46E4831

P2093

Q34976915-1268B315-05EE-4870-AF5F-1A7D14B6B86D

Q34976915-4F1CB7B9-C934-4FB4-9D8B-CCF302BBBB2A

Q34976915-AB519D30-9BE7-4BDE-8459-1B0AAD2EBA8D

Q34976915-D48B9F9B-8A81-4B7C-813C-C343506E73F7

P2860

Q34976915-02AE2BA8-2B8A-4A09-B328-B13F7B552A22

Q34976915-03BFE40C-D5D5-4BC7-8AB4-D6F3353B2830

Q34976915-0551C6FD-9D4B-4CB9-962C-6CF3F7501592

Q34976915-060C55D4-9842-41EE-BF05-BF78ACB7BC3B

Q34976915-084D82FE-B689-4564-A9E2-34B9C8D192DB

Q34976915-10CF1A68-ACAD-4A76-A239-FC88A584DB17

Q34976915-14FF0CEC-170E-4303-9D9B-D97420B71EB0

Q34976915-19D7DA99-ED90-4997-A455-D80FA29EAC2C

Q34976915-1DC12971-1980-4B9B-AF51-778298130225

Q34976915-1FA80962-5E45-428B-8BBC-2F17DCAFB5BE

P304

Q34976915-650F5B1A-6FA0-4E04-92EB-5BA5F9E2714B

P31

Q34976915-AF3F3EEC-927D-47E7-923F-7A6F7E1B3B16

P356

Q34976915-0E122DEE-AC8F-4F2A-94B2-16A15B81FDAA

P407

Q34976915-4B482025-5F95-4B3E-A13F-4ADF76996579

P433

Q34976915-6CC1709A-ED31-4E51-829E-3834A04CAE23

P478

Q34976915-A92C35D3-3A7E-47A5-A05D-7163B3B628D8

P577

Q34976915-CCCC39C1-DA67-49A4-9524-163EB8DAB5FF

P698

Q34976915-1518B792-C9DC-426E-A340-41F24A2F44D9

P921

Q34976915-FE0D46C6-2D7D-433A-B5C8-BDF22B8000CE

P932

Q34976915-D2D1857B-3342-4CF4-86F6-8F51FAB79F7E

P356

CIRCULATIONAHA.109.914820

P1433

P1476

Pharmacogenomics: the genetics of variable drug responses.

@en

P2093

C Michael Stein

http://www.w3.org/2001/XMLSchema#string

Dan M Roden

http://www.w3.org/2001/XMLSchema#string

Heyo K Kroemer

http://www.w3.org/2001/XMLSchema#string

Russell A Wilke

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide association of lipid-lowering response to statins in combined study populations

Finding the missing heritability of complex diseases

A comprehensive review of genetic association studies

Clinical assessment incorporating a personal genome

Genetic predictors of interindividual variability in hepatic CYP3A4 expression

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Medical genetics: a marker for Stevens-Johnson syndrome

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

P304

1661-1670

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.109.914820

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21502584

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

3093198

http://www.w3.org/2001/XMLSchema#string